Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001415889-16-007110
Filing Date
2016-09-12
Accepted
2016-09-12 16:37:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D defrancesco13d_sept122016.htm SC 13D 59296
2 TRANSACTIONS IN SHARES ex1-1.htm EX-1.1 50412
  Complete submission text file 0001415889-16-007110.txt   111148
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Subject) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79102 | Film No.: 161881325
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 365 BAY STREET SUITE 840 TORONTO A6 M5H 2V1
Business Address
DeFrancesco Catherine Johanna DeFrancesco (Filed by) CIK: 0001684226 (see all company filings)

Type: SC 13D